LANDER COSCARART: Open Payments
NPI 1467932798 · JEFFERSON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| LEO Pharma Inc. | 3 | $75 |
| Incyte Corporation | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Journey Medical Corporation | 1 | $27 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14 |
Products named: ADBRY, RINVOQ, OPZELURA, TREMFYA, SKYRIZI, Sotyktu, Neo-Synalar, TALTZ.
Industry payments across LA — which companies pay providers there.
